insights_auto
Sebab NXTCL menurun 2.93%?
Terokai Dengan Lebih Terperincichevron_right
NXTCL:STO
NextCell Pharma AB
SEK 0.25
arrow_downward
-2.93%(-0.0075) 1H
11 Nov, 5:08:33 PTG GMT+1 · SEK
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk NXTCL...
Buka
SEK 0.25
Tinggi
SEK 0.26
Rendah
SEK 0.24
Permodalan Pasaran
31.85J
Purata volum
1.01J
Volum
190.06K
tgi 52 mgu
SEK 1.78
rdh 52 mgu
SEK 0.20
EPS
-SEK 0.45
Syer tertunggak
111.39J
Bilangan pekerja
21
Buka
SEK 0.25
Tinggi
SEK 0.26
Rendah
SEK 0.24
Permodalan Pasaran
31.85J
Purata volum
1.01J
Volum
190.06K
tgi 52 mgu
SEK 1.78
rdh 52 mgu
SEK 0.20
EPS
-SEK 0.45
Syer tertunggak
111.39J
Bilangan pekerja
21
Cerita berita
Daripada sumber web dan rakan kongsi berita
Eurasia Business News
·
1 jam lalu
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Rally on November 11, 2026; Oil Rises, Gold Slips
BeInCrypto
·
48 minit lalu
S&P 500 Sits 2.5% From a Record High Despite the Stock Market Crash
The Motley Fool
·
42 minit lalu
History Says 1 Month Has Been the S&P 500's Most Reliable Since 1950. It's Only Weeks Away.
Profil
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
Perihal NextCell Pharma AB
CEOMathias Svahn
Pekerja21
Diasaskan19 Mac 2014
Ibu pejabat-
SektorHealth Care
Industri-
Laman webnextcellpharma.com